A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease.
Riddell, L A
A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease. [electronic resource] - AIDS research and human retroviruses Jun 2001 - 789-97 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0889-2229
10.1089/088922201750251981 doi
AIDS-Related Opportunistic Infections--prevention & control
Anti-Infective Agents--adverse effects
Consumer Product Safety
Double-Blind Method
HIV-1
Humans
Interferon-gamma--adverse effects
Recombinant Proteins
A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease. [electronic resource] - AIDS research and human retroviruses Jun 2001 - 789-97 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0889-2229
10.1089/088922201750251981 doi
AIDS-Related Opportunistic Infections--prevention & control
Anti-Infective Agents--adverse effects
Consumer Product Safety
Double-Blind Method
HIV-1
Humans
Interferon-gamma--adverse effects
Recombinant Proteins